Saiying Capital key facts
- Saiying Capital is a other based in Beijing, China with 6 tracked portfolio companies.
- Notable positions include GeneCradle, Arthrone, Cyberpai (Wuxi) Technology.
About Saiying Capital
Saiying Capital is a direct investment firm based in Beijing, China. Established in 2016, the firm was established by Saisheng Pharmaceutical (SZ: 300485) in cooperation with E-town International Investment and E-town Biomedical Park. The core of its investment strategy is made up of M&A and direct investment. The firm seeks to make investments in the healthcare sector. The assets are managed by the executive management team.
Saiying Capital portfolio at a glance
6 portfolio companies are on record for Saiying Capital, including GeneCradle, Arthrone and Cyberpai (Wuxi) Technology.
2 of the 6 carry a recorded valuation.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Free account
See more of the book
- ·The top 10 names in the book — of 6 recorded positions
- ·Watchlist + alerts for Saiying Capital's activity
Portfolio
6 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| GeneCradle | — | ▮ | ▮ | ▮ |
| Arthrone | — | ▮ | ▮ | ▮ |
| Cyberpai (Wuxi) Technology | — | ▮ | ▮ | ▮ |
+ 3 more companies · all 6, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Frequently asked about Saiying Capital
- What companies does Saiying Capital invest in?
- Saiying Capital has 6 recorded portfolio companies, including GeneCradle, Arthrone, Cyberpai (Wuxi) Technology.